logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 138 – Cannabis Sales May Surpass Soda by 2030

Life Science & Technology Weekly 138 – Cannabis Sales May Surpass Soda by 2030

Published on: Apr 5, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Agriculture Biotechnology Blockchain Healthcare Services Life Science Technology

Related Posts

Rasonque's Lightning Approval Validates Druckenmiller's Bet on Revolution Medicines

Rasonque’s Lightning Approval Validates Druckenmiller’s Bet on Revolution Medicines

MRVL Slumps on Google Deal Hangover, Wall Street Shrugs

Three Biotech Stocks Crushed the S&P 500 — Analysts Still Back Just One

Clinical-Stage Biotechnology Company Biohaven Sees Dual Positive Developments During the Week

Is The Metals Company Still the King of Deep Sea Mining?

AI, Starlink, and Rockets: Is SpaceX a $2 Trillion Bargain – or a Bubble?

BitGo Acquires NYDIG Business Lines, Reshaping Institutional Crypto Infrastructure Landscape

8月27日之后,英伟达股价有可能反弹吗?

From Chips to Ecosystem, What Drives NVIDIA’s Sky-High Acquisition of the “GitHub of AI”?

Related News

Nvidia Takes $21 Billion Stake in SpaceX as Huang Deepens Musk Ties

7 hours ago.

Rasonque’s Lightning Approval Validates Druckenmiller’s Bet on Revolution Medicines

9 hours ago.

Clinical-Stage Biotechnology Company Biohaven Sees Dual Positive Developments During the Week

13 hours ago.

AI, Starlink, and Rockets: Is SpaceX a $2 Trillion Bargain – or a Bubble?

14 hours ago.

Top Stories

Rasonque's Lightning Approval Validates Druckenmiller's Bet on Revolution Medicines
Life Science

Rasonque’s Lightning Approval Validates Druckenmiller’s Bet on Revolution Medicines

Why ASML and TSMC Are the Two Best Ways to Play the AI Memory Boom Without the Cyclical Risk
Technology

Why ASML and TSMC Are the Two Best Ways to Play the AI Memory Boom Without the Cyclical Risk

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada